| Literature DB >> 35336443 |
Bea Essers1, Camilla Biering Lundquist2, Geert Verheyden1, Iris Charlotte Brunner2,3.
Abstract
We examined factors associated with different aspects of upper-limb (UL) activity in chronic stroke to better understand and improve UL activity in daily life. Three different aspects of UL activity were represented by four sensor measures: (1) contribution to activity according to activity ratio and magnitude ratio, (2) intensity of activity according to bilateral magnitude, and (3) variability of activity according to variation ratio. We combined data from a Belgian and Danish patient cohort (n = 126) and developed four models to determine associated factors for each sensor measure. Results from standard multiple regression show that motor impairment (Fugl-Meyer assessment) accounted for the largest part of the explained variance in all sensor measures (18-61%), with less motor impairment resulting in higher UL activity values (p < 0.001). Higher activity ratio, magnitude ratio, and variation ratio were further explained by having the dominant hand affected (p < 0.007). Bilateral magnitude had the lowest explained variance (adjusted R2 = 0.376), and higher values were further associated with being young and female. As motor impairment and biological aspects accounted for only one- to two-thirds of the variance in UL activity, rehabilitation including behavioral strategies might be important to increase the different aspects of UL activity.Entities:
Keywords: determinants; stroke; upper-limb sensor activity
Mesh:
Year: 2022 PMID: 35336443 PMCID: PMC8951346 DOI: 10.3390/s22062273
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Definitions for sensor measures.
| Activity ratio [ | Ratio of the total activity hours of the affected UL compared to the unaffected UL, reflecting the relative contribution of the affected UL over the entire monitoring period. |
| Magnitude ratio [ | Contribution of each arm to activity, calculated for each second of activity. |
| Bilateral magnitude [ | Summed intensity of activity across both arms, calculated for each second of activity. |
| Variation ratio [ | Ratio of acceleration variability of the affected UL compared to the unaffected UL, reflecting the relative variability in the affected UL over the entire monitoring period. |
Demographic and stroke-related characteristics presented as medium (SD), median (Q1–Q3), or number (%).
| Belgian Cohort ( | Danish Cohort | All Participants | |
|---|---|---|---|
| Age at inclusion (years) | 59 (13) | 66 (10) | 62 (12) |
| Gender (male), | 37 (62) | 40 (61) | 77 (61) |
| Days since stroke onset | 977 (577–1618) | 182 (179–185) | 193 (182–880) |
| Stroke etiology (ischemia), | 37 (62) | 54 (82) | 91 (72) |
| Lateralization (left hemisphere), | 28 (47) | 31 (47) | 59 (47) |
| Dominant side affected, | 27 (45) | 33 (50) | 60 (48) |
| Hand dominance (right), | 52 (87) | 58 (88) | 110 (87) |
| Living arrangement, | |||
| Living alone | 29 (48) | 48 (73) | 77 (61) |
| Living not alone | 31 (52) | 18 (27) | 49 (39) |
| FMA-UE | 53 (27–62) | 58 (47–63) | 57 (34–62) |
| Affected UL use | 3.80 (1.88) | 3.95 (1.91) | 3.88 (1.89) |
| Activity ratio | 0.66 (0.27) | 0.72 (0.27) | 0.69 (0.27) |
| Median magnitude ratio | −2.06 (−7–−0.51) | −0.93 (−3.11–−0.35) | −1.30 (−7–−0.37) |
| Median bilateral magnitude | 90.99 (66.24–114.72) | 95.39 (73.11–114.01) | 94.15 (67.90–114.01) |
| Variation ratio | 0.57 (0.29) | 0.64 (0.28) | 0.61 (0.29) |
FMA-UE: Fugl–Meyer Assessment upper extremity.
Standard multiple regression models to examine the association between various independent factors and different sensor measures.
| Unstandardized Coefficients | Standardized Coefficient | Change Statistics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Dependent | Independent | B | SE | β | 95% CI for β | Significance | Adjusted Model | SEE | Significant F Change | |
| Activity ratio | FMA-UE | 0.011 | 0.001 | 0.781 | 0.685 to 0.872 | <0.001 * | 0.605 | |||
| Dominant side affected | 0.098 | 0.028 | 0.181 | 0.081 to 0.280 | <0.001 * | 0.033 | ||||
| Constant | 0.140 | 0.038 | <0.001 * | |||||||
| Model | 0.663 | 0.157 | <0.001 ꭛ | |||||||
| Magnitude ratio | FMA-UE | 0.108 | 0.007 | 0.769 | 0.665 to 0.869 | <0.001 * | 0.579 | |||
| Dominant side affected | 1.534 | 0.418 | 0.277 | 0.106 to 0.462 | <0.001 * | 0.036 | ||||
| Right-hemispheric lesion | 1.083 | 0.418 | 0.195 | 0.027 to 0.383 | 0.011 * | 0.018 | ||||
| Hemorrhagic stroke | −0.742 | 0.321 | −0.120 | −0.230 to −0.017 | 0.023 * | 0.014 | ||||
| Constant | −8.780 | 0.551 | <0.001 * | |||||||
| Model | 0.668 | 1.601 | <0.001 ꭛ | |||||||
| Bilateral magnitude | FMA-UE | 0.673 | 0.111 | 0.432 | 0.290 to 0.574 | <0.001 * | 0.181 | |||
| Age | −0.642 | 0.182 | −0.254 | −0.397 to −0.111 | <0.001 * | 0.062 | ||||
| Male | −12.001 | 4.586 | −0.191 | −0.335 to −0.046 | 0.010 * | 0.035 | ||||
| Hemorrhagic stroke | −11.745 | 4.904 | −0.172 | −0.341 to −0.030 | 0.018 * | 0.029 | ||||
| Constant | 113.330 | 13.061 | <0.001 * | |||||||
| Model | 0.376 | 24.309 | <0.001 ꭛ | |||||||
| Variation ratio | FMA-UE | 0.011 | 0.001 | 0.738 | 0.654 to 0.836 | <0.001 * | 0.540 | |||
| Dominant side affected | 0.094 | 0.033 | 0.163 | 0.055 to 0.273 | 0.006 * | 0.026 | ||||
| Constant | 0.055 | 0.045 | 0.222 | |||||||
| Model | 0.587 | 0.185 | <0.001 ꭛ | |||||||
95% CI: 95% confidence interval; SEE: standard error of estimate; sr2: semi-partial correlation. * The β-coefficient was statistically significant. ꭛ The model R2 change was statistically significant.